PR Newswire - MEDIPOST Secures FDA Agreement on Single Pivotal P...
SEOUL, South Korea, June 4, 2026 /PRNewswire/ -- MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to con...
Read More

ภาษาไทย
English